SIX1 and breast carcinoma: In breast cancer, SIX1 activates extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways, which result in the transformation of mammary epithelial cells and increase the proliferation of cancer stem cells (CSCs) [24, 25].